Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2012 Issues
|
Issue 1019
IAC Express: Weekly immunization news and information
Issue 1019: October 9, 2012


TOP STORIES

IAC HANDOUTS

OFFICIAL RELEASES AND ANNOUNCEMENTS

FEATURED RESOURCES

JOURNAL ARTICLES AND NEWSLETTERS

EDUCATION AND TRAINING

CONFERENCES AND MEETINGS



TOP STORIES

CDC makes important changes to its recommendations for vaccine storage and handling
CDC recently made several important changes to its recommendations for vaccine storage and handling. They are published in the document Interim Vaccine Storage and Handling Guidance. The introduction is reprinted below.

In response to recent scientific studies on equipment used for vaccine storage and a better understanding of best practices for vaccine storage and handling, the Centers for Disease Control and Prevention (CDC) is providing interim guidance on appropriate vaccine storage and handling practices. This guidance is intended for use by all public and private sector providers and, while recognizing that cost may be a barrier, we encourage practices to move toward implementing these recommendations as soon as possible. CDC is currently evaluating the most efficient and cost effective method to phase these recommendations in and more guidance is forthcoming.

With the goal of improving the way providers store and handle vaccines nationwide, several important changes have been made to previous recommendations issued by CDC, including:

1. Use of a biosafe glycol-encased probe or a similar temperature buffered probe rather than measurement of ambient air temperatures, and;
2. Use of digital data loggers with detachable probes that record and store temperature information at frequent programmable intervals for 24 hour temperature monitoring rather than non-continuous temperature monitoring, and;
3. Use of stand-alone refrigerator and stand-alone freezer units suitable for vaccine storage rather than combination (refrigerator+freezer) or other units not designed for storing fragile biologics, such as vaccines, and;
4. Discontinuing use of dorm-style or bar-style refrigerator/
freezers for ANY vaccine storage, even temporary storage, and;
5. Weekly review of vaccine expiration dates and rotation of vaccine stock


Related Links
Back to top


Spotlight on immunize.org: reminder to consider using IAC’s newest educational materials for patients and staff
To help healthcare professionals carry out their immunization activities, IAC wants to remind you that in the past year we have created several new educational materials for patients and staff. Please review them to see if they might be of help to you in your work setting.
  1. Influenza Vaccination of People with a History of Egg Allergy
  2. Meningococcal Vaccination Recommendations by Age and/or Risk Factor
  3. Current Dates of Vaccine Information Statements (VISs)
  4. Tips for Locating Old Immunization Records
  5. Decision to Not Vaccinate My Child
  6. How to Administer Intramuscular, Intradermal, and Intranasal Influenza Vaccines
  7. Keep Your Kids Safe–Get them Vaccinated Every Fall or Winter!
Related Links
Back to top


Shortage of Pentacel and Daptacel vaccines to continue throughout March 2013 
On October 5, CDC updated its Current Vaccine Shortages & Delays web section with the information reprinted below.

Availability of Sanofi Pasteur's Pentacel® and DAPTACEL® vaccines is currently reduced and it is anticipated that this will continue throughout March of 2013. Sanofi Pasteur’s single antigen inactivated polio and Hib vaccines are in sufficient supply to address historic usage of Pentacel® as well as the single antigen vaccines. Regarding DTaP, production and supply of GSK's single antigen and combination vaccines is currently sufficient to address anticipated supply gaps for DTaP-containing products.

Back to top


CDC publishes report on U.S.-acquired human rabies in which onset and diagnosis occurred abroad
CDC published U.S.-Acquired Human Rabies with Symptom Onset and Diagnosis Abroad, 2012 in the October 5 issue of MMWR (pages 777–781). A press summary of the article is reprinted below.

This study documents the first reported case of human rabies acquired in the United States in which onset and diagnosis occurred abroad. On July 8, 2012, a 34 year old male U.S. citizen died of rabies in Switzerland after onset of symptoms in Dubai, United Arab Emirates. Public health investigations identified a potential bat contact approximately 12–13 weeks before he became ill. Fifty-nine persons were identified with potential contact with the patient while he was infectious and 23 persons have initiated post-exposure prophylaxis (PEP). This case highlights the need for international collaboration to identify, notify, assess, and provide prophylaxis to all those who had potential contact with a rabies infected individual.

Back to top


CDC publishes an update on U.S. and worldwide influenza activity during May 20–September 22, 2012
CDC published Update: Influenza Activity—United States and Worldwide, May 20–September 22, 2012 in the October 5 issue of MMWR (pages 785–789). A press summary of the article is reprinted below.

The United States experienced low levels of seasonal influenza activity from May 20 to September 22, 2012; however more seasonal influenza viruses were detected in the summer months of previous years. Influenza A (H3N2), 2009 influenza A (H1N1), and influenza B viruses were detected worldwide and in the United States. Since July 12, 306 cases of influenza A (H3N2) variant virus have been detected. Although neither the influenza virus strain(s) that will predominate nor the severity of influenza-related disease during the 2012–13 influenza season can be predicted, characterization of viral isolates from specimens submitted during the summer demonstrated that the vast majority were antigenically similar to the influenza vaccine strains in the Northern Hemisphere 2012–13 vaccine.

Back to top


CDC publishes report on recent progress Afghanistan and Pakistan made in eradicating poliomyelitis
CDC published Progress Toward Poliomyelitis Eradication—
Afghanistan and Pakistan, January 2011–August 2012
in the October 5 issue of MMWR (pages 790–795). A press summary of the article is reprinted below.

Afghanistan and Pakistan are two of the three remaining countries (the third is Nigeria) in which indigenous wild poliovirus (WPV) transmission has never been interrupted and remain a substantial threat to the Global Polio Eradication Initiative goal of a polio-free world. This report updates previous MMWR yearly reports and describes polio eradication activities and progress in Afghanistan and Pakistan during January 2011–August 2012, as of September 9, 2012. During this time period, WPV type 1 transmission occurred in conflict-affected areas in the South Region of Afghanistan and in three groups of districts in Pakistan. In addition to transmission within each country, lab data confirms cross-border transmission resulting from substantial population movements. Positive environmental sewage samples in Pakistan, in areas with no recent confirmed cases, highlight unrecognized continued polio transmission. To achieve polio eradication, both Afghanistan and Pakistan might consider reviewing how their national emergency action plans address commitment, management, and oversight by provincial and district authorities, as well as cross-border transmission of WPV and the safety of vaccination teams in insecure areas.

Back to top


IAC HANDOUTS

IAC's checklists for vaccine contraindications have all been updated
IAC recently updated and renamed the following checklists for vaccine contraindications.
  1. Screening Checklist for Contraindications to Inactivated Injectable Influenza Vaccination, (formerly titled "Screening Questionnaire for Inactivated Injectable Influenza Vaccination")
  2. Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination (formerly titled "Screening Questionnaire for Live Attenuated Intranasal Influenza Vaccination")
  3. Screening Checklist for Contraindications to Vaccines for Adults (formerly titled "Screening Questionnaire for Adult Immunization")
  4. Screening Checklist for Contraindications to Vaccines for Children and Teens (formerly titled "Screening Questionnaire for Child and Teen Immunization")
Related Link
IAC's Handouts for Patients and Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.

Back to top


OFFICIAL RELEASES AND ANNOUNCEMENTS

Minnesota Department of Health updates its Tdap recommendations to include 10-year-olds
The Minnesota Department of Health (MDH) recently updated its recommendation for the use of Tdap vaccine to address the state's ongoing pertussis epidemic. Minnesota has reported more than 3500 cases of pertussis this year, and is on track to triple the highest number of cases reported annually in recent years.

The revised recommendation retains the previous direction to keep the pertussis vaccination of infants, children, under-vaccinated 7–10 year olds, and adults up to date. It adds direction for vaccinating the state's children with Tdap starting at age 10 years. It advises clinicians to vaccinate a child who presents in clinic, but it does not advise a broad recall of 10–12-year-old patients for vaccination.

Related Link
Back to top


FEATURED RESOURCES

CDC posts lots of resources to help immunization professionals promote influenza vaccination
CDC is encouraging public and private healthcare providers to promote influenza vaccination to people in communities across the nation. It has made a variety of free materials available for all audiences. Following is a listing of them.
  • Find print, audio/video, social media tools, and web tools (including an expanded selection of materials for American Indian and Alaska Natives) at the Free Resources web page
     
  • Check out CDC's new Information for Flu Prevention Partners web section, where partners are already entering activities into the calendar of events for the 2012–2013 flu season. Submit your flu prevention activities/events and see what others are planning now
     
  • Visit CDC's main website, Seasonal Influenza (Flu),  to read relevant Q&As; get the latest information on the H3N2v virus; learn more about the most recent ACIP recommendations; keep up with national and international flu activity, surveillance, and vaccine coverage data; or view information tailored specifically for healthcare professionals
     
  • Direct your influenza-related questions and information requests (including those concerning web content syndication or how to get updates via subscription) to CDC at fluinbox@cdc.gov
Back to top


CMS's provider Communication Group distributes information about Medicare to providers
Part of the Centers for Medicare & Medicaid Services (CMS), the Provider Communication Group (PCG) has an extensive communications network. It includes national, state, and local distribution, with large provider reach. PCG distributes Medicare information and news messages via 18 national Medicare Fee-for-Service (FFS) provider listservs; Medicare Administrative Contractor (MAC) listservs; Medicare's 10 regional offices’ listservs; and the CMS and MAC websites. In addition, PCG distributes to national provider partner organizations through the CMS Medicare FFS Provider e-News and the social media sites Twitter and LinkedIn. 

CMS Medicare FFS Provider e-News (e-News)
The e-News is PCG’s primary communications vehicle with its national provider partners. The e-News is distributed via email every week and includes messaging on a variety of topics of interest to the FFS healthcare community. View the October 4, 2012, issue.

1. The e-News is distributed weekly to 187 national associations and organizations and more than 2,700 local organizations through Medicare's regional offices.
2. It reaches approximately 4.7 million providers and staff throughout the country.

National Medicare FFS Provider Listservs and MAC Listservs
Messages are also distributed through the National Medicare FFS Provider listservs. Messages are sent to individuals who subscribe to these listservs.

1. National Medicare FFS Provider Listservs—approximately 108.9 K subscribers
2. MAC Listservs—approximately 671.9K subscribers

PCG will distribute information and news related to the 2012–2013 flu season through the communications network described above, as it becomes available.

Related Link
Back to top


JOURNAL ARTICLES AND NEWSLETTERS

September 2012 issue of CDC's Immunization Works newsletter now available
CDC recently released the September 2012 issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter is made available to national healthcare provider and consumer groups for distribution to their members and constituencies. The immunization information included is non-proprietary and is encouraged to be widely disseminated and shared.

The September issue contains information about what has been going on in immunization in the past month. Much of it has already been covered in previous issues of IAC Express.

Back to top


CDC corrects information published in the September 28 MMWR on influenza H3N2v hospitalizations
CDC published Erratum: Vol. 61, No. 38 in the October 5 issue of MMWR (page 802). It is reprinted below.

In the printed version of the report "Influenza A (H3N2) Variant Virus-Related Hospitalizations—Ohio, 2012," an error occurred on p. 764, in the third sentence of the second paragraph. The sentence should read as follows: "Respiratory specimens were confirmed as positive for H3N2v virus by testing at the Ohio Department of Health (ODH) laboratory using the CDC FLU real-time reverse transcription polymerase chain reaction (rRT-PCR) Dx Panel for influenza A (H3N2)v and at CDC by rRT-PCR and genetic sequencing (1)." The online versions have been corrected.

Back to top


EDUCATION AND TRAINING

CDC posts web-on-demand version of the August 16 broadcast of Immunization Update; CE credit available
The web-on-demand version of CDC's August 16 Immunization Update is available for viewing and study.

Related Links
Back to top


CONFERENCES AND MEETINGS

ACIP meeting scheduled for October 24–25 in Atlanta; registration deadline is Wednesday, October 10
The Advisory Committee on Immunization Practices (ACIP) will hold its next meeting on October 24–25 at CDC's Clifton Road campus in Atlanta. To attend the meeting, ACIP attendees (participants and visitors) must register online by October 10.

The ACIP web section has detailed information about the meeting, including access to online registration, live webcast instructions, and the meeting agenda.

Back to top


Missouri Immunization Conference planned for November 15–16 in St. Louis
The Missouri Immunization Conference will be held in St. Louis on November 15–16. It is sponsored by the Gateway Immunization Coalition, in partnership with the Missouri State Department of Health and Senior Services,  Bureau of Immunization Assessment and Assurance. Keynote speakers include Gary Marshall, MD, University of Louisville; epidemiologist William Atkinson, MD, MPH; and Mark Grabowsky, MD, National Vaccine Program Office, Department of Health and Human Services.

Conference and registration information is available.

Back to top



About IAC Express 
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: Baxter Healthcare Corp.; CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104


Copyright (C) 2012 Immunization Action Coalition
All rights reserved.
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Video: Whooping Cough Shot: Does It Last?
Whooping Cough Shot: Does It Last?: Dr. Swanson, AKA Seattle Mama Doc, discusses the results of a New England Journal of Medicine study on the duration of protection against pertussis following vaccination with DTaP.
Related link: NEJM article
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on October 9, 2012
 
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.